A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

January 16, 2020

Study Completion Date

January 8, 2021

Conditions
Coronary Artery Disease
Interventions
DEVICE

SYNERGY 48 mm

A drug eluting coronary stent system

Trial Locations (15)

2025

Auckland City Hospital, Auckland

10032

New York Presbyterian Hospital - Columbia University Medical Center, New York

17403

York Hospital, York

27607

Rex Hospital, Raleigh

35294

University of Alabama at Birmingham, Birmingham

45219

Lindner Center for Research and Education at Christ Hospital, Cincinnati

55102

HealthEast St. Joseph's Hospital, Saint Paul

75024

The Heart Hospital Baylor Plano, Plano

75226

Baylor Heart & Vascular Hospital, Dallas

Unknown

P. Stradins University Hospital, Riga

0622

North Shore Hospital, Takapuna

BT12 6BA

Royal Victoria Hospital, Belfast

G81 4DY

Golden Jubilee National Hospital, Glasgow

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

OX3 9DU

John Radcliffe Hospital, Oxford

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY